RCMI Coordinating Center (RCMI CC)
Home
About
RCMI Coordinating Center
Overview
Sharing Data
Network Graph
Help
History (6)
Isotonic Solutions
Koro
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression.
Impact of Myeloid Reservoirs in HIV Cure Trials.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impact of Myeloid Reservoirs in HIV Cure Trials.
Mitchell BI, Laws EI, Ndhlovu LC. Impact of Myeloid Reservoirs in HIV Cure Trials. Curr HIV/AIDS Rep. 2019 04; 16(2):129-140.
View in:
PubMed
subject areas
Anti-Retroviral Agents
CD4-Positive T-Lymphocytes
Clinical Trials as Topic
HIV Infections
HIV-1
Humans
Myeloid Cells
Virus Latency
authors with profiles
Brooks Mitchell, PhD
Lishomwa Ndhlovu, MD PhD